Mechanistically, we showed using both cellular and molecular-based assays that the TGFβ-TGFβR1-SMAD2/3 is at least involved in the transition of AF cells and BMSCs towards a stronger pro-fibrotic phenotype. The gene discussed is TGFBR1; the disease is atrial fibrillation.